Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 16Thoracic 4Head & Neck 4Gynecologic 3Genitourinary 3Dermatologic 3CNS 2Other solid neoplasm 1Breast 1

Conditions

Mesothelioma 17Mesothelioma, Malignant 15Solid Tumor 10Carcinoma, Non-Small-Cell Lung 8Advanced Solid Tumors 8Melanoma 6Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Advanced Solid Tumor 5Solid Tumors 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Small Cell Lung Carcinoma 3Ovarian Neoplasms 3Carcinoma, Transitional Cell 3Carcinoma, Merkel Cell 3Advanced or Metastatic Solid Tumors 3Turcot syndrome 2Stomach Neoplasms 2Neoplasm Metastasis 2Malignant Solid Tumor 2Lung Neoplasms 2Endometrial Neoplasms 2Colorectal Neoplasms 2Cholangiocarcinoma 2Wilms Tumor 1Vulvar Neoplasms 1Vaginal Neoplasms 1Urinary Bladder Neoplasms 1

Interventions

obinutuzumab 1naptumomab estafenatox 1durvalumab 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Squamous Cell Carcinoma × Nivolumab × Other solid neoplasm × Clear all
NCT06034860 2024-11-01

Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types

Molecular Templates, Inc.

Phase 1 Terminated
15 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Melanoma, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡